Technology | May 01, 2012

Theragenics Receives FDA Clearance for Galt VTI Valved Tearaway Introducer

New product in offers ergonomic, low-profile integrated valve

May 1, 2012 — Theragenics Corp. announced that Galt Medical, a wholly-owned subsidiary of Theragenics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Galt VTI valved tearaway introducer. Introducers are utilized for vascular access, with the Galt VTI expected to be utilized primarily for placing catheters.

The Galt VTI is a tearaway introducer that includes an ergonomic low-profile patent-pending integrated valve. The Galt VTI allows surgeons the ability to introduce or provide access for other medical devices to enter into a patient’s vascular system, reducing the risk of an air embolism and leakage. The Galt VTI is a less bulky and a more compact design than similar products currently available.

The addressable market in the United States for the Galt VTI is estimated to be approximately $14 million of annual sales and growing at 5 percent annually. The Galt VTI is expected to launch in the second half of 2012, with revenue in the range of $300,000 expected based on indications of interest from Galt Medical’s customer base. Within 12 months of launch, the company expects the Galt VTI to generate annualized revenue of $1 million to $2 million, with gross profit margins higher than currently being realized in Galt Medical’s surgical products segment.

“Both current and potential new customers have expressed significant interest in the Galt VTI product,” said M. Christine Jacobs, chairwoman and CEO of Theragenics Corp. “We expect this product to be a valuable addition to our current vascular access product platform, offering important new features along with the same high quality to which our customers are accustomed.

“The Galt VTI product is the most significant internally developed product released by our surgical products segment to date. We intend to continue to focus on the development of new products that can utilize the FDA 510(k) clearance process in all our business units,” added Jacobs.

Galt Medical is a wholly-owned subsidiary of Theragenics. The Galt business unit manufactures and distributes vascular access products, including introducers and guidewires used in interventional radiology, interventional cardiology and vascular surgery. Theragenics operates two business segments: its surgical products business and its brachytherapy seed business.

For more information: www.theragenics.com

Related Content

COVID-19 outbreak in Seattle cancels SIR 2020 meeting. Interventional radiology meeting cancelled. #COVID19 #coronavirus #2019nCoV
News | Interventional Radiology | March 09, 2020 | Melinda Taschetta-Millane
March 9, 2020 — As the novel coronavirus (COVID-19) slowly spreads across the globe, more industry conferences are de
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 11, 2020
February 11, 2020 — An ahead-of-print...
New SIR position statement and quality documents highlight interventional radiology effective use of nonsurgical ablation to treat kidney cancer in selected patients
News | Interventional Radiology | February 04, 2020
February 4, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the Soci
Smart Speaker Technology Harnessed for Hospital Medical Treatments
News | Interventional Radiology | April 10, 2019
Smart speakers customarily used in your living room can act as an aid to physicians in hospital operating rooms,...
NZ Technologies Announces First Peer-Reviewed Paper on TIPSO AirPad
News | Interventional Radiology | March 25, 2019
NZ Technologies Inc. announced the first published clinical review on its TIPSO technology’s ability to provide...
Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter
Technology | Interventional Radiology | June 29, 2018
Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation...
Guerbet Launches Pair of Microcatheters for Interventional Radiology Procedures
Technology | Interventional Radiology | May 23, 2018
Guerbet LLC USA announced the upcoming launch of SeQure and DraKon, two novel microcatheters for tumor and vascular...
U.S. First Lady Melania Trump Undergoes Interventional Radiology Embolization Procedure
News | Interventional Radiology | May 15, 2018
U.S. First Lady Melania Trump underwent an interventional radiology embolization procedure to treat a benign kidney...
Capitol Hill Briefing Explores Role of Interventional Radiology in Healthcare
News | Interventional Radiology | May 09, 2018
The Society of Interventional Radiology (SIR), in conjunction with Rep. Mia Love (R-Utah) participated in a panel...
Overlay Init